A 24-year-old woman from York has become one of the first patients in the world to take part in a pioneering research study at Sheffield Teaching Hospitals NHS Foundation Trust that could switch off the progression of a rare, incurable muscle-weakening disorder called facioscapulohumeral muscular dystrophy (FSHD).